Overview

A Single and Multiple Ascending Dose Study of Niclosamide in Healthy Volunteers

Status:
Recruiting
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
A single and multiple ascending dose study of ANA001 in healthy adults to assess the safety and pharmacokinetics
Phase:
Phase 1
Details
Lead Sponsor:
ANA Therapeutics
NeuroBo Pharmaceuticals Inc.
Treatments:
Niclosamide